Jay M. Short Ph.D., Chief Executive Officer at BioAtla, Inc. (BCAB), bought 26,350 shares at $7.84 ($207K) on 2022-08-12, disclosed to the SEC on 2022-08-15.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| BCAB | BUY | 2022-06-23 | $397K | — | Filing → |
| BCAB | SELL | 2021-12-07 | $2.1M | — | Filing → |
| BCAB | SELL | 2021-12-06 | $737K | — | Filing → |